Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel ...

According to a new comprehensive report from The Insight Partners, the global patient-derived xenograft model market is ...

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Lactiga, a biotech company leading the development of naturally-occurring antibody therapies for inflammatory and immunodeficient conditions, has been ...

Join Mick D. Edmonds, PhD, Assistant Professor and Director, Genetic and Genomic Sciences Program at University of Alabama, Birmingham, where he’ll review the results of a new study evaluating the ...

To address this, senescent human lung fibroblasts, or their secretome (SASP), were instilled into the lungs of immunodeficient mice. The researchers found that human senescent fibroblasts engraft ...

In this webinar, we will introduce the generation and applications of Biocytogen’s severely immunodeficient (B-NDG) mice for preclinical research studies. B-NDG mice lack B, T, and NK cells, which ...

SARS-CoV-2 viral ribonucleic acid (RNA) carriage in the nasopharynx of immunodeficient COVID-19 patients was for shorter durations, which was attributed to the serological response to vaccination ...

Management of measles in immunodeficient patients and patients with other conditions that heighten the risk of severe disease requires a comprehensive approach (see Assessment and Treatment).